Medical management of cutaneous malignancies

Clinics in Dermatology

Volumn 19, Issue 3, 2001, Pages 298-304

  Gibbs, Peter ^a   Gonzalez, Rene ^a   Lee, Lela A ^a   Walsh, Patrick ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANTINEOPLASTIC AGENT; AZELAIC ACID; BLEOMYCIN SULFATE; CHLORMETHINE; CISPLATIN; CLADRIBINE; COSMOGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DENILEUKIN DIFTITOX; DOXORUBICIN; ETOPOSIDE; ETRETIN; ETRETINATE; FLUDARABINE PHOSPHATE; FLUOROURACIL; IMIQUIMOD; INTERLEUKIN 2; ISOTRETINOIN; METHOTREXATE; METHOXSALEN; PACLITAXEL; PREDNISONE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT INTERLEUKIN 2; RETINOID; TAMOXIFEN CITRATE; TAZAROTENE; UNCLASSIFIED DRUG; VINBLASTINE SULFATE; VINCRISTINE SULFATE;

ADVERSE DRUG REACTION; BASAL CELL CARCINOMA; DRUG EFFICACY; DRUG INDICATION; HUMAN; KAPOSI SARCOMA; LIVER TOXICITY; MELANOMA; MERKEL CELL TUMOR; PRIORITY JOURNAL; REVIEW; SKIN LYMPHOMA; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; LYMPHOMA, T-CELL; MELANOMA; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0034912096     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(01)00173-0     Document Type: Review

References (68)

1. Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms
2. Treatment of Bowen's disease with topical dinitrochlorobenzene and 5-fluorouracil
3. Nonsurgical treatments for skin cancer; retinoids and alpha-interferon
4. Topical chemotherapy for squamous cell carcinoma
5. Topical chemotherapy for basal cell carcinoma
6. Tumors of the skin. IV. Double-blind study of effects of local administration of anti-tumor agents in basal cell carcinoma
7. Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma
8. Tumors of the skin. VII. Effects of varying the concentration of locally administered 5-fluorouracil on basal cell carcinoma
9. Tumors of the skin. XII. Topical 5-fluorouracil for epidermal neoplasms
10. Topical chemotherapy of advanced cutaneous malignancy with 5-fluorouracil cream
11. Use of 5 fluorouracil in the topical therapy of skin cancer; A review of 157 patients
12. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma
13. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient
14. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
15. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
16. Topical tretinoin enhances percutaneous absorption of 5-fluorouracil in vitro
17. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil
18. Topical tretinoin treatment in basal cell carcinoma
19. Fluorouracil paste treatment of thin basal cell carcinomas
20. Cryosurgery and topical fluorouracil; a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome
21. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma
22. studies in 2-acetylaminofluorene carcinogenesis III. The utilization of uracil-2-C14 by preneoplastic rat liver and rat hepatoma
23. Studies on the induction of thymine deficiency and on the effects of thymine and thymidine analogs in Escherichia coli
24. Fluorinated pyrimidines, a new class of tumor inhibitory compounds
25. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma
26. Proceedings; Chemotherapy and immunotherapy for cancer involving the skin
27. Bowenoid conditions of the skin; Treatment with topical 5-fluoruracil
28. Selective cytotoxic effect of topical 5-fluorouracil
29. Noninflammatory destruction of actinic keratoses by fluorouracil
30. Treatment of Bowen's disease with topical dinitrochlorobenzene and 5-fluorouracil
31. Use of 5 fluorouracil in the topical therapy of skin cancer; A review of 157 patients
32. Systemic treatment for advanced cutaneous melanoma
33. A Phase III randomized trial of DTIC, Cisplatin, BCNU and Tamoxifen versus DTIC alone in patients with metastatic melanoma
34. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma; long-term survival update
35. Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease
36. Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
37. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma
38. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma)
39. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin; case series and review of 204 cases
40. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma
41. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants
42. Regression of AIDS-related Kaposiís sarcoma following treatment with an HIV-1 protease inhibitor
43. Highly active antiretroviral therapy in HIV-related Kaposiís sarcoma
44. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection; a Canadian HIV Clinical Trials Network study
45. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study
46. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome
47. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma
48. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group
49. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma; results of a pilot phase II study
50. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid; results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group
51. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group
52. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma; results of a randomized phase III clinical trial
53. Kaposiís sarcoma. New treatment modalities
54. Kaposi's sarcoma in renal transplant recipients. Experience at Johannesburg Hospital, 1966-1989
55. Clinical features and course of Kaposi's sarcoma in kidney transplant patients; report of 13 cases
56. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma
57. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma
58. Systemic therapy for cutaneous T-cell lymphoma. (mycosis fungoides and Sezary syndrome)
59. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome
60. Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II
61. Bexarotene (Targretin) for cutaneous T-cell lymphoma
62. Chemotherapy for mycosis fungoides and the Sezary syndrome
63. 2-Chlorodeoxyadenosine; An active agent in the treatment of cutaneous T-cell lymphoma
64. Phase II study of pentostatin and intermittent high-dose recombinant interferon alpha-2 in advanced mycoses fungoides/Sezary syndrome